New diagnostic and therapeutic tools
against multidrug resistant tumours

Participation in meetings

STRATAGEM members attend international science and technology related conferences not specifically organized by our COST Action. In such meetings, STRATAGEM scientists promote the objectives and results of our action.

Presentations at extramural meetings
Riganti C.
Nitric oxide-releasing gemcitabine: a new weapon against pancreatic cancer?
2nd INTERNATIONAL CONFERENCE Therapeutic Applications of Nitric Oxide in Cancer and Inflammatory-related Diseases.

03-05/03/2022
De Las Rivas J.
STRATAGEM: a COST Action on New diagnoses and therapies against Multi-Drug Resistant tumours.
7th Annual meeting of the French Society for Nanomedecine.

06-08/12/2021
Riganti C.
Which are the advancements of the nano-based theranostic approach to lung cancer?
Nanotechnology and chronic lung diseases (Webinar event).

22/01/2021
Riganti C.
P-Glycoprotein Inhibitors: “old” chemosensitizers, “new” immune-sensitizers.
2nd International Conference on Drug Discovery and Drug Development (Webinar event).

21-22/10/2020
Ntungwe E, Isca V, Tavares J, Vágvölgyi M, Saraiva L, Spengler G, Hunyadi A, Rijo P.
Cytotoxic activity of coleon diterpenoids from Plectranthus mutabilis Codd.
5th International Electronic Conference on Medicinal Chemistry.

01-30/11/2019
Ntungwe E, Isca V, Vágvölgyi M, Tavares J, Spengler G, Hunyadi A, Rijo P.
Bio-guided isolation and biological activity of diterpenes from Plectranthus mutabilis Codd.
Modern Methods of Structural Elucidation (MMSE). Lisbon

21-25/10/2019
Ntungwe E, Isca V, Vágvölgyi M, Tavares J, Domínguez-Martína EM, Díaz-Lanza AM, Spengler G, Hunyadi A, Rijo P.
Isolation of two bioactive diterpenes from Plectranthus mutabilis Codd.
I Bio.Natural. Lisbon

28-29/09/2019
Tsakovska I, Alov P, Pencheva T, Lessigiarska I, Tzankova V, Aluani D, Yordanov Y, Saponara S, Fruttero R, Pajeva I.
ADME/Tox evaluation of H2S-releasing doxorubicin as a promising lead, effective against doxorubicin-resistant cells: in silico and in vitro studies.
12th Asian Federation for Medicinal Chemistry (AFMC) International Medicinal Chemistry Symposium. Istanbul

08-11/09/2019
Belisario DC, Morena D, Di Nicolantonio F, Gazzano E, Cordero F, Hattinger CM, Taulli R, Serra M, Kopecka J, Riganti C.
The small nucleolar RNAs: new players in osteosarcoma chemoresistance?
1st International & 32nd Annual Conference of Italian Association of Cell Culture. Catanzaro

01-02/09/2019
Ananthanarayanan P, Lingua M, Mohr T, Novello S, Righi L, Scagliotti G, Taulli R, Riganti C.
Identifying unique molecular targets and using novel gene group based shotgun treatments in malignat pleural mesothelioma
1st International & 32nd Annual Conference of Italian Association of Cell Culture. Catanzaro

01-02/09/2019
Ntungwe E, Isca V, Vágvölgyi M, Spengler G, Hunyadi A, Rijo P.
Bio-guided phytochemical study of Plectranthus mutabilis Codd.
67th International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA) in cooperation with the French Society of Pharmacognosy AFERP. Innsbruck

01-05/09/2019
Riganti C.
Mitochondria metabolism: a driver of chemoresistance or an Achille’s heel? Metabolism meets function
Torino

19/07/2019
Ntungwe E, Isca V, Vágvölgyi M, Spengler G, Hunyadi A, Rijo P.
Isolation and Biological activity study of coleon U from Plectranthus mutabilis Codd.
4th scientific meeting of CQUL (4ECQUL), on Chemistry: Shaping the future. Lisbon

16-19/07/2019
Ntungwe E, Isca V, Vágvölgyi M, Tavares J, Spengler G, Hunyadi A, Rijo P.
Bio-guided isolation and biological activity of diterpenes from Plectranthus mutabilis Codd.
Ciência 2019. Lisbon

08-10/07/2019
Ananthanarayanan P, Kopecka J, Ricci L, Riganti C.
Targeting SCF complex and proteins turnover to overcome chemoresistance and trigger innate anti-tumor immune response in malignant pleural mesothelioma
2nd International Proteomics and Metabolomics Conference. Verona

01/07/2019
Italian Mass Spectrometry Division Award for the best communications
Salaroglio IC, Gazzano E, Belisario CD, Kopecka J, Riganti C.
ABCA1, ABCB1 and ABCC1 trio determines chemo-immuno-resistance in cancer cells
2nd Workshop Molecular, cellular and translational approaches to differentiation and neoplastic transformation. Firenze

17/06/2019

Invited lecture; Oral presentation; Poster.